Skip to content

The effects of electroacupuncture on the muscle cramps of liver cirrhosis patients - randomized controlled study

The effects of electroacupuncture on the muscle cramps of liver cirrhosis patients - randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0001356
Enrollment
24
Registered
2015-01-23
Start date
2015-02-02
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : After screening, patients be randomly allocated to treatment and control group. Treatment group receive 25 minute duration of electroacupuncture, three times a week for 4 weeks. The

Sponsors

Comprehensive and Integrative Medical Institute
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Frequency of muscle cramps: more than once every 2 weeks irreguarding sites of cramps 2. Serum bilirubin: less than 5 mg/dL 3. Serum AST and ALT: less than 200 U/L, each 4. Serum creatinine: less than 2.0 mg/dL 5. INR: less than 2.0 6. Age is more than 18 years olds who voluntarily decide the participation of the study and sign the consent. 7. The patients who can be possible to follow up during the study periods. 8. The patients who accord with the wash-out criteria and agree to keep the restriction rule during the study

Exclusion criteria

Exclusion criteria: 1. The patients who accompany other disease evoking muscle crapms such as vessel occlusive disease, peripheral neuropathy, postphlebitic syndrome, thyroids disease. 2. Absolute granulocyte counts: less than 500/mm3 3. Platelet counts: less than 50,000/mm3 4. The patient who have no sign of aggrevation of HCC such as fever, deterioration of liver function, abdominal aortic aneurysm, venous thrombosis 5. The patients who is inappropriated this study confirmed by researchers 6. Women who have posive urine hCG.

Design outcomes

Primary

MeasureTime frame
The frequency and duration of muscle cramps

Secondary

MeasureTime frame
Child-Pugh score, Adverse events and overall safety

Countries

Korea, Republic of

Contacts

Public ContactChang Hyeong Lee

Daegu Catholic Univercity Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026